Articles Tagged: "McGill"
Even though iNovia Capital doesn’t do Life Sciences investments anymore (since 2009), we still have two amazing bio-pharma portfolio companies under management, and we are excited to share with you some recent developments only made possible because of the entrepreneurial team that forms this company – Mimetogen Pharmaceuticals. Launched in 2005, Mimetogen was founded… Continue Reading
MSBI Inc., a provider of seed and early stage venture capital for the commercialization of innovations in life sciences, information technology and physical sciences, announced the close of MSBI LP, its $26 million seed and early-stage venture capital fund. MSBI LP will fund technology-based businesses in sectors such as biotechnology, pharmaceuticals, bioinformatics, software, communications & networking
… Continue Reading